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The Australian sheep blowﬂy, Lucilia cuprina, is an ecto-parasite that causes signiﬁcant economic losses
in the sheep industry. Emerging resistance to insecticides used to protect sheep from this parasite is
driving the search for new drugs that act via different mechanisms. Inhibitors of histone deacetylases
(HDACs), enzymes essential for regulating eukaryotic gene transcription, are prospective new in-
secticides based on their capacity to kill human parasites. The blowﬂy genome was found here to contain
ﬁve HDAC genes corresponding to human HDACs 1, 3, 4, 6 and 11. The catalytic domains of blowﬂy HDACs
1 and 3 have high sequence identity with corresponding human and other Dipteran insect HDACs (Musca
domestica and Drosophila melanogaster). On the other hand, HDACs 4, 6 and 11 from the blowﬂy and the
other Dipteran species showed up to 53% difference in catalytic domain amino acids from corresponding
human sequences, suggesting the possibility of developing HDAC inhibitors speciﬁc for insects as desired
for a commercial insecticide. Differences in transcription patterns for different blowﬂy HDACs through
the life cycle, and between the sexes of adult ﬂies, suggest different functions in regulating gene tran-
scription within this organism and possibly different vulnerabilities. Data that supports HDACs as
possible new insecticide targets is the ﬁnding that trichostatin A and suberoylanilide hydroxamic acid
retarded growth of early instar blowﬂy larvae in vitro, and reduced the pupation rate. Trichostatin A was
8-fold less potent than the commercial insecticide cyromazine in inhibiting larval growth. Our results
support further development of inhibitors of blowﬂy HDACs with selectivity over human and other
mammalian HDACs as a new class of prospective insecticides for sheep blowﬂy.
© 2015 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology. This is an
open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).1. Introduction
The Australian sheep blowﬂy, Lucilia cuprina, is an important
parasite of sheep in Australia. Adult L. cuprina females are attracted
to sheep odours, particularly those associated with bacterial in-
fections in damp ﬂeece, or areas of ﬂeece or skin soiled by urine or
faeces (Watts et al., 1981; Emmens and Murray, 1983). In these
regions of high humidity, each female ﬂy lays approximately 200
eggs per batch. The eggs hatch and develop into larvae that abrade
the skinwith their mouth hooks, and secrete digestive proteases, to
initiate the blowﬂy strike lesion (Sandeman et al., 1987, 1990). Thermody Rd. St. Lucia, Queens-
).
r Ltd on behalf of Australian Socielarvae feed for several days, causing severe tissue damage, toxae-
mia and, in some cases, mortality. Blowﬂy strike is responsible for
production losses in the Australian sheep industry amounting to
over $AUD280M per annum (Sackett et al., 2006). The control of the
parasite relies largely on the use of insecticides applied to the sheep
as preventative treatments. These chemicals remain active against
larvae hatching from freshly-laid eggs on the sheep for several
months. However, the blowﬂy has now developed resistance to
some of these insecticides, with organophosphate- and
benzoylphenylurea-based products no longer being effective
(Sandeman et al., 2014). Resistance to the widely-used substituted
diaminotriazine compound cyromazine has also been reported
recently (Levot, 2012; Levot et al., 2014). As the Australian sheep
industry currently relies on such insecticides derived from this
single chemical family to which resistance has been detected, there
is an urgent need for new insecticides that preferably have aty for Parasitology. This is an open access article under the CC BY license (http://
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Histone deacetylase (HDAC) enzymes are essential regulators of
gene transcription in all eukaryotic organisms, catalysing removal
of acetyl groups from lysine sidechains of nucleosomal histone
proteins (Kou and Allis, 1998). They act in conjunction with histone
acetyltransferases (which catalyse the reverse reaction) to control
the degree to which histones are acetylated, and hence gene
transcription patterns in cells. HDACs have been recognised as
therapeutic targets in cancer for many years (Cairns, 2001), with
more than ten HDAC inhibitors currently in use in the clinic or in
clinical trials as anti-cancer drugs. HDAC inhibitors are also being
studied for inhibition of human parasitic infections, including
malaria, toxoplasmosis, trypanosomiasis, schistosomiasis and
leishamaniasis (Andrews et al., 2009, 2012). In insects the effects of
HDAC inhibitors have been reported on gene transcription patterns
in Drosophila melanogaster and on the activity of individual re-
combinant HDAC enzymes (Foglietti et al., 2006; Cho et al., 2005).
There has been a single report examining the lethality for an HDAC
inhibitor (trichostatin A) on D. melanogaster (Pile et al., 2001). The
compound inhibited adult eclosion following exposure to embryos,
and larvae failed to fully develop. We were therefore interested in
the potential of HDAC inhibitors to be a new class of insecticides.
This study aimed ﬁrstly to identify all HDAC genes present in L.
cuprina, taking advantage of the recently completed blowﬂy
genome (Anstead et al., 2015), and to compare the blowﬂy HDAC
genes with those of other insects and mammals. This information
may also inform other prospective uses of HDAC inhibitors more
broadly as insecticides other than for the control of the sheep
blowﬂy alone. Knowledge on differences between insect and
mammalian forms is crucial in order to ensure speciﬁcity and safety
of HDAC inhibitors applied to sheep for blowﬂy control, or to other
mammals as insecticides. We examined HDAC gene expression
patterns through the life cycle of the blowﬂy in order to identify the
best HDAC enzymes to target, and when the insect is potentially
most vulnerable. Chemotherapeutic approaches to the control of
the sheep blowﬂy are best directed at the larval life stages present
on sheep, as it is not practical to target adult ﬂies due to their
mobility. Hence, information provided here on the expression of
HDAC genes in early larval life stages is important in assessing their
value as new drug targets for blowﬂy control. Finally, to establish
proof of concept, two compounds that inhibit most HDAC enzymes
were examined for toxicity against blowﬂy larvae using an in vitro
bioassay, and compared to commercial blowﬂy insecticides. For this
exercise, we chose to examine trichostatin A (TSA) because it is a
well-known and potent pan-HDAC inhibitor (Yoshida et al., 1995)
used widely to study HDAC inhibition in vitro. Suberoylanilide
hydroxamic acid (SAHA, vorinostat) was also examined as this is
perhaps the most common HDAC inhibitor used in vivo and in
clinical studies, and is also approved for human use to treat cuta-
neous lymphomas (Iwamoto et al., 2013).
2. Materials and methods
2.1. Insects and chemicals
The L. cuprina ﬂies used in this study were from the laboratory
reference drug-susceptible LS strain. This strain was derived from
collections in the Australian Capital Territory, and has no history of
exposure to insecticides. It has been maintained in the laboratory
for >40 years. Adult ﬂies were kept at 28 C and 80% relative hu-
midity with a daily photoperiod of LD 16: 8 h. Adults were main-
tained on a diet of sugar and water; larvae were raised on a
wheatgerm culturemedium as described by Tachibana and Numata
(2001). Gravid females were allowed to oviposit onto bovine liver
before eggs were transferred to the wheatgerm culture mediumshortly afterwards.
Trichostatin A (TSA), tylosin solution (8 mg/mL) and dicyclanil
were purchased from Sigma Chemical Co., diﬂubenzuron and
cyromazine from ChemService, and suberoylanilide hydroxamic
acid (SAHA, vorinostat) from Cayman Chemical Co.
2.2. Lucilia cuprina HDAC genes
The recently-completed L. cuprina genome (Anstead et al., 2015)
was searched using sequences for human HDACs 1e11. Homolo-
gous sequences in L. cuprina (E-value cut-off:  105) were
conﬁrmed by comparisons to human, D. melanogaster and Musca
domestica (houseﬂy) sequences in the National Center for
Biotechnology Information database. Molecular phylogenetic
analysis was conducted in MEGA6 (Tamura et al., 2013). The
maximum likelihood method was used to construct a phylogenetic
tree for the catalytic domain amino acid sequences for ﬁve HDACs
from each of the three Dipteran species, as well as human HDACs
1e11. We used the percent identity matrix created by Clustal2.1 to
generate identity matrix tables to separately compare the catalytic
domains of each of the blowﬂy HDACs with those of the other two
Dipterans and humans.
2.3. Life stage transcription proﬁling
Blowﬂies were collected at various stages through the life cycle
in order to examine HDAC transcription patterns. All samples were
snap frozen immediately in liquid nitrogen, and stored at 80 C.
Larval life stages were cultured in 70 mL containers as described by
Kotze et al. (2014). Eggs were harvested (Day 0) by placing a slice of
liver into a cage of mature adult ﬂies from approximately
1200 he1400 h. The liver slice covered in eggs was then removed,
and batches of approximately 25 mg were added to 2 mL screw top
vials containing a mixture of 0.1, 1.0 and 2 mm zirconian/silica
beads (Biospec Products) and snap frozen. The remaining eggs were
retained on the liver, and placed at room temperature in the dark
overnight. The next morning (Day 1), batches of 25 mg of freshly
hatched larvae were collected and snap frozen. A number of cul-
tures were established by placing 50 larvae into containers with
four layers of Whatman number 1 ﬁlter paper (GH Healthcare) and
0.2 g of chopped cotton wool soaked with 2.5 mL of a nutrient
medium consisting of 80 g/L yeast extract (Merck) and 1.6 mg/mL
tylosin (Sigma) in lamb serum (Life Technologies) buffered with
35 mM KH2PO4.2H20, pH7.5. The larvae were fed with 1 mL of
nutrient medium on Day 1, and then 2 mL on each of Days 2 and 3.
Larvae were sampled on Days 2 (n¼ 20 individuals), 3 (n¼ 4) and 4
(n ¼ 4) from the pots and snap frozen. The stage of development of
larvae on Days 2, 3 and 4 was determined by examination of the
posterior spiracle openings in 4 individuals (1, 2 and 3 openings
expected for each spiracle in 1st, 2nd and 3rd instars, respectively).
Late on Day 4, the containers were placed into large pots with a
layer of sand at the base to serve as a medium for pupation, and
returned to the incubator. Pupae were sampled on Days 7 and 11,
and snap frozen (4 individual pupae per sample). On Day 11, the
remaining pupae were separated from the sand on a sieve, and
placed into cages containing water and sugar cubes, at 28 C (80%
relative humidity, photoperiod of LD 16: 8 h). On Day 15, adult ﬂies
were collected, anaesthetised using CO2, and 3 males and 3 females
were recovered and snap frozen. A slice of liver was placed into the
cage on Day 16 to provide a protein meal for the adult ﬂies. Samples
of male and female ﬂies (n¼ 3) were again taken on Days 19 and 23.
Three separate time course experiments were performed.
RNA was extracted using an RNeasy kit (Qiagen, Hilden, Ger-
many), as per the manufacturer's instructions, with initial ho-
mogenisation by shaking on a Powerlyzer 24 (Mo Bio Laboratories).
Fig. 1. Schematic representation of the ﬁve blowﬂy (Lc) HDAC proteins, and their
human (Hs) homologues, with the catalytic domains shaded. The amino acid lengths of
the proteins are shown on the left, and the lengths of the catalytic domains are shown
above each domain. The start and end amino acids for the catalytic domains are given
at each end of the domains. The two catalytic domains of HDAC6 are shown as 6.1 and
6.2.
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drop and treated with TurboDnase (Ambion) to remove any
genomic DNA. RNA quality was assessed using an Agilent Bio-
analyser. cDNA synthesis was performed on extracted RNA using
SuperScript III Reverse Transcriptase (Lifetechnologies), according
to the manufacturer's instructions.
Quantitative PCR primers were designed for each of the blowﬂy
HDAC genes using Primer 3 software (Koressaar and Remm, 2007;
Untergrasser et al., 2012) (Supplementary Table 1). Five house-
keeper genes (18S rRNA, 28S rRNA, b-tubulin, RPLPO and GST1)
were used as references for the normalisation of data across the
various time points (Bagnall and Kotze, 2010). A 7900HT thermo-
cycler (Applied Biosystems) was used with the SYBR Green dye
system (Applied Biosystems) and the following PCR cycling con-
ditions: 50 C for 2 min, 95 C for 10 min, followed by 40 cycles
95 C for 15 s, 60 C for 1 min, 95 C for 2 min, 60 C for 15 s. PCRs
were run in quadruplicate. Reaction efﬁciencies were determined
by performing PCRs using a series of four, 5-fold cDNA dilutions.
Standard curves for all primer pairs indicated an efﬁciency range
between 86 and 99%. Melting curve analysis of each primer pair
identiﬁed the qPCR products to be homogenous.
The data were analysed using REST 2009 software in a two-step
process:
i) Initially, each life stage was compared separately to the Day 1
ﬁrst instar larval stage as the control sample. In this way the
transcription of each HDAC was expressed relative to the tran-
scription level of that speciﬁc HDAC on Day 1. This provided
information on relative levels of transcription at the different
time points within a speciﬁc HDAC.
ii) Secondly, the relative transcription levels of each HDAC in the
Day 1 time point were compared. This allowed for the tran-
scription levels across the ﬁve HDAC genes to be expressed
relative to HDAC1 on Day 1, and hence provided a means to
derive relative transcription values across all genes and all time
points using the data generated in part i) above; for instance, if
HDAC3 was transcribed at 10-fold lower levels on Day 8 than on
Day 1 (from part i)), and if HDAC3 was expressed at 5-fold lower
levels than HDAC1 on Day 1 (from part ii)), then the expression
levels after correction became HDAC1 Day1 ¼ 1, HDAC3
Day1 ¼ 0.2, HDAC3 Day 8 ¼ 0.02. In this way all the data were
corrected to show transcription relative to HDAC1 on Day 1
which was assigned a value of 1.
Three separate relative transcription values were derived for
each HDAC at each time point using the quantitative PCR date from
the three separate time course experiments. The data were ana-
lysed using ANOVA following log10 transformation. Signiﬁcant
differences between the different time points for each HDAC, as
well as between HDACs at each time point, were identiﬁed using
Tukey's multiple comparison test at P ¼ 0.05.
2.4. Bioassays
The effect of the HDAC inhibitors TSA and SAHA on larval growth
was assessed using a bioassay system inwhich larvae were allowed
to develop on cotton wool impregnated with the compounds at
various concentrations (modiﬁed slightly from Kotze et al., 2014).
The assay was in the format described above for the culturing of
larvae for HDAC transcription proﬁling except that the cotton wool
in each assay container was impregnated with drug prior to the
addition of 50 freshly-hatched larvae on Day 0. The potency of the
two HDAC inhibitors was compared to three commercial blowﬂy-
control chemicals, cyromazine, dicyclanil and diﬂubenzuron. TSA
and SAHA were prepared as stock solutions at 1 mg/mL in ethanol,while diﬂubenzuron was prepared at 1 mg/mL in acetone, and
cyromazine and dicyclanil at the same concentration in distilled
water. These stock solutions were kept at 80 C. Working solu-
tions, consisting of 4-fold dilutions in the various solvents, were
also stored at80 C. Aliquots of these solutions (4 mL) were added
to the cotton wool in bioassay containers one day prior to the
addition of larvae, and the solvents allowed to evaporate overnight
in a fume hood. Control containers were prepared by addition of
4 mL ethanol to the cotton wool.
In order to calculate mean larval weight at the beginning of the
drug exposure period, two groups of 100 larvae were collected,
blotted dry on paper towel, weighed and discarded on Day 0. After
24 h (Day 1), 3 larvae were removed from each container, weighed,
and discarded. The remaining larvae were fed with nutrient me-
dium on days 2 and 3, and then placed into the larger pupation
containers, as described above. On Day 10, the pupae were sepa-
rated from the sand on a sieve, and the pupae were counted. Each
compound was examined at either three of four 5-fold serially
diluted concentrations. Each experiment consisted of a single
container at each concentration of HDAC inhibitor or insecticide,
alongside 4 control assays. Three separate experiments were
performed.
The effect of the compounds on larval development was deﬁned
in two ways:
i) effect on larval weight gain over the ﬁrst 24 h by expressing the
total weight gain of the 3 larvae sampled on Day 1 as a per-
centage of the mean of the weight gain of the 3 larvae sampled
from each of the 4 control containers (weight gain measured
using the mean weight of larvae on Day 0 as an initial weight);
ii) effect on the pupation rate by expressing the number of pupae
in each drug-treated container as a percentage of the mean
number of pupae in the 4 control containers.
The larval weight and pupation rate doseeresponse datawere
analysed with GraphPad Prism® software using non-linear
regression, with the ‘variable slope’ option selected, in order
to calculate IC50 values (with 95% Conﬁdence Intervals) repre-
senting the concentration of inhibitor required to reduce the
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control (no drug) treatments.3. Results
Examination of the sheep blowﬂy genome revealed the pres-
ence of ﬁve HDAC genes with sequences corresponding to human
HDAC1, HDAC3 (both Class I HDACs), HDAC4 (Class IIa), HDAC6
(Class IIb), and HDAC11 (Class IV). We therefore named the blowﬂy
genes as follows: LcHDAC1 (GenBank accession no. FF38_03544),
LcHDAC3 (FF38_01208), LcHDAC4 (FF38_13781), LcHDAC6
(FF38_14519) and LcHDAC11 (FF38_06169). Comparisons between
the human and blowﬂy full-length amino acid sequences showed
amino acid identities for HDAC1, 3, 4, 6 and 11 of 78%, 68%, 59%, 44%
and 55%, respectively. The blowﬂy and human HDAC proteins are
represented schematically in Fig. 1, with the catalytic domains
highlighted. Both the full protein and catalytic domain lengthswere
similar for each blowﬂy and corresponding human HDAC. The
phylogenetic relationships between the catalytic domains of the
blowﬂy HDAC genes, those from two other Dipteran insects
(D. melanogaster and M. domestica) and those from humans are HsHD
0.2
Fig. 2. Phylogenetic tree illustrating relationships between the amino acid sequences of th
versus human (Lc Lucilia cuprina, MdMusca domestica, Dm Drosophila melanogaster, Hs Homo
to scale, with branch lengths measured as the number of substitutions per site.shown in Fig. 2. The insect genes showed greater relatedness to
each other than to the human genes in each case. Branch lengths
separating the insect and human amino acid sequences were
generally longer for the Class IIb and Class IV HDACs than for Class I
and IIa.
The relatedness of the HDACs from the 4 organisms was
examined further by comparing the percent identity of the catalytic
domain amino acid residues for the three insects and humans
(Fig. 3). The insecteinsect comparisons showed greater degrees of
identity than any insect-human comparison. Importantly, this
analysis showed signiﬁcant amino acid differences between insect
and humanHDAC proteins, particularly for HDACs 4, 6 (both 6.1 and
6.2) and HDAC11. The two catalytic domains of human HDAC6
showed only 46e53% amino acid identity to the equivalent do-
mains in the three insects, while human HDAC4 and 11 showed
53e62% identity with the insects. HDAC 1 was the most similar in
the three insects and humans.
The transcription patterns for the ﬁve blowﬂy HDAC genes
through the life cycle are shown in Fig. 4. The data were expressed
with reference to the transcription level of HDAC1 at the second
time point of the experiment (that is, at the freshly-hatched larval LcHDAC1
 MdHDAC1
 DmHDAC1
 HsHDAC1
 HsHDAC2
 LcHDAC3
 MdHDAC3
 DmHDAC3
 HsHDAC3
 HsHDAC8
 LcHDAC4
 MdHDAC4
 DmHDAC4
 HsHDAC4
 HsHDAC5
 HsHDAC9
 HsHDAC7
 LcHDAC6.1
 MdHDAC6.1
 DmHDAC6.1
 HsHDAC6.1
 HsHDAC10
 LcHDAC6.2
 MdHDAC6.2
 DmHDAC6.2
AC6.2
 LcHDAC11
 MdHDAC11
 DmHDAC11
 HsHDAC11
e catalytic domains of the eleven zinc-containing HDACs from three Dipteran species
sapiens). The analysis was conducted in MEGA6 (Tamura et al., 2013). The tree is drawn
Fig. 3. Comparison of HDAC catalytic domain amino acid residues between three
Dipteran insects (Lc Lucilia cuprina, Md Musca domestica, Dm Drosophila melanogaster)
and humans (Hs Homo sapien). Each separate ﬁgure component shows the percentage
identity of amino acids in comparisons between pairs of species, for each HDAC gene.
The values are taken from a percent identity matrix created by Clustal2.1.
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spiracle openings in larvae at each of the sampling time points
across the larval phase of the experiment showed that the larvae
were 1st instar on day 1, 2nd instar on day 2, and 3rd instar on days
3 and 4. The highest transcription of HDACs 1 and 3 occurred in the
egg stage and in day 23 adult females, with transcription at these
two stages being equivalent within each gene, at levels signiﬁcantly
higher than all the other life stages (Fig. 4A). Transcription of
HDAC4 was higher in eggs than the other life stages, except for 19
day and 23 day females. The pattern was similar for HDAC6, with
transcription in eggs higher than all the larval stages, alongside
being equivalent to 19 and 23 day females and males. Within each
HDAC, adult male ﬂies showed equivalent transcription levels at
each of the adult sampling times (days 15, 19 and 23). On the other
hand, female ﬂies showed signiﬁcantly higher transcription levels
at day 23 compared to day 15 for each of HDACs 1, 3, 4 and 6.
Transcription patterns for HDACs 1, 3, 4 and 6 in the larval life stages
alone, and themean larval weight on each day, are shown in Fig. 4B.
On days 1 and 2, HDAC6 was transcribed at equivalent levels to
HDAC1, but was signiﬁcantly higher than HDACs 3 and 4. On days 3
and 4, transcription of HDAC6 was higher than all the other genes.
Transcription levels were generally lower for HDAC 11 than for
the other genes, especially in the larval stages, and hence, for clarity,
it is presented separately (Fig. 4C and D). The transcription level was
signiﬁcantly lower throughout the larval stages than the level for
HDAC1 on day 1 thatwas used as a reference point (with an assigned
value of 1, as described above). HDAC11 did not exhibit the peak in
the egg stage observed for HDACs 1, 3, 4 and 6 (Fig. 4C). Transcription
remained at least 30-fold less than HDAC1 across the larval life
stages (Fig. 4D). Adult males on days 19 and 23 showed higher levels
of transcription than the larval stages, while female ﬂies showed
equivalent levels to larvae across the three adult time points.
As proof of concept that HDAC enzymes might be useful targets
for inhibition of blowﬂy growth, two pan-HDAC inhibitors wereassessed alongside three commercial blowﬂy-control chemicals in
in vitro bioassays for monitoring inhibition of growth of blowﬂy
larvae. Dose-response curves (Fig. 5) compare the potencies of
compounds in inhibiting growth of larvae during the ﬁrst 24 h after
egg hatch (Fig. 5A), as well as their effects on pupation rate (Fig. 5B).
IC50 values are shown in Table 1. Both HDAC inhibitors showed
dose-dependent inhibition of larval weight gain and pupation. TSA
was more toxic than SAHA, 42- and 64-fold more potent in
reducing weight and pupation, respectively. TSAwas 8-and 90- fold
less effective in inhibition of larval weight gain over the ﬁrst 24 h
than the commercial insecticides, cyromazine and dicyclanil,
respectively. TSA and the three commercial insecticides each
showed equivalent IC50 values for the weight gain and pupation
measurements (overlapping 95% CIs for IC50s within each drug),
while for SAHA the pupation IC50 was signiﬁcantly greater than the
weight gain IC50.
4. Discussion
A blowﬂy control agent must be directed at larval stages of
blowﬂies feeding on sheep rather than the mobile adult stages that
more widely inhabit the environment. A blowﬂy molecular target
for an insecticide must therefore be present in larval stages, pref-
erably in early larval stages (ﬁrst and second instar), as they need to
be killed before they extensively damage the host. Our transcription
proﬁling has shown that the blowﬂy HDACs are generally tran-
scribed at the highest levels in eggs and adult life stages, however
each of the genes was also transcribed at readily detectable levels in
the larval life stages. The peaks in egg and adult stages for HDACs 1,
3 and 4 are in general agreement with the patterns in
D. melanogaster (Cho et al., 2005), whereas the peak in blowﬂy
HDAC6 in eggs was not evident in D. melanogaster.
There was some commonality in the life-stage transcription
patterns for the various blowﬂy HDACs, as well as key differences.
For example, while transcription was generally highest in the eggs
and in adult female ﬂies for HDACs 1, 3, 4 and 6, HDAC11 did not
show the peak in eggs. While transcription levels for HDACs 1, 3, 4
and 6 in adult males showed no change over the three adult sam-
pling time points, levels of each gene increased signiﬁcantly in fe-
males at day 23 compared to day 15. In addition, while HDACs 1 and
3 showed increases in adult females at day 23 compared to the
larval stages, for HDAC11 only the adult males showed increases
above larval levels. These different patterns most likely indicate
different roles for the HDACs across the blowﬂy life cycle. Tran-
scription proﬁling, RNA interference, and inhibitor studies with
D. melanogaster have also suggested different roles for different
HDACs in that ﬂy, with evidence that individual HDACs regulate the
transcription of distinct sets of genes (Cho et al., 2005; Foglietti
et al., 2006).
This study has shown that the potent HDAC inhibitor TSA has
signiﬁcant toxicity towards the larval life stages of the sheep
blowﬂy, thereby highlighting the potential of HDAC inhibitors to act
as insecticides for sheep blowﬂy. Moreover, the potency of TSAwas
within 8-fold of a current blowﬂy control chemical, supporting the
principle of inhibiting HDAC enzymes as a viable approach to a new
kind of commercial insecticide. SAHA was signiﬁcantly less toxic
than TSA, consistent with similar differences between their relative
potencies for killing cancer cells (Marks and Breslow, 2007) and
parasites (Andrews et al., 2009) and inhibiting inﬂammatory dis-
eases (Halili et al., 2009), and is simply due to differences in their
relative cell permeabilities coupled with their relative afﬁnities for
HDAC enzymes inside cells (Gupta, 2012). The pupation IC50 for
SAHA was greater than that for weight gain in the ﬁrst 24 h, sug-
gesting that the insecticidal effects of this compound decreased
over the time course of the bioassay, and, hence, some larvae were
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during the ﬁrst 24 h of the assay. In contrast, the more potent TSA
behaved in a similar manner to the commercial insecticides in
showing equivalent IC50 values for the two measurements, simply
reﬂecting its high potency.
A degree of insect speciﬁcity will be essential for any HDAC in-
hibitor to be used in the ﬁeld as an insecticide. While TSA provides
evidence for the lethality of a HDAC inhibitor to a Dipteran insect,
this compound inhibits all HDAC enzymes and cannot itself be
considered a viable insecticidal agent. The next goal will be to
generate compounds that can selectively inhibit blowﬂy HDACs
without affecting human, mammalian or other non-target insect
HDACs. The selectivity of HDAC inhibitors as anti-parasitic agents
more generally has only recently begun to be evaluated. There haveFig. 4. Transcriptomic proﬁling of HDAC genes across the blowﬂy life cycle. A: HDACs 1, 3, 4
with solid lines, adult males with dashed lines; B: HDACs 1, 3, 4, and 6 in the larval stages o
points for larvae, pupae and adult females joined with solid lines, adult males with dashed
point represents mean ± SE, n ¼ 3 separate experiments. All data expressed relative to tranbeen reports of selectivity of some HDAC inhibitors for malaria
parasites versus mammalian cell lines (for example, Andrews et al.,
2008; Dow et al., 2008; Wheatley et al., 2010), highlighting the
potential to design inhibitors to selectively target non-mammalian
HDAC enzymes. Our examination of HDAC catalytic domain amino
acid sequences in the sheep blowﬂy and two other Dipteran insects,
alongside the equivalent human proteins, provides some optimism
that such insect speciﬁcity may be achievable. The catalytic domain
amino acids of sheep blowﬂy HDACs 4, 6.1, 6.2 and 11 differed by up
to 53% from the human homologs. Further analysis will be required
to determinewhether these amino acid differences affect the active
site of the HDAC enzymes themselves, and hence are more likely to
provide a degree of selectivity in the inhibitor actions, or whether
they are at sites less important for inhibitor binding.and 6 across the whole life cycle; time points for larvae, pupae and adult females joined
nly; larval weight shown as a dashed line; C: HDAC11 across the whole life cycle; time
lines. D: HDAC11in larval stages only; larval weight shown as a dashed line. Each data
scription of HDAC1 on Day 1 (freshly-hatched larvae), which was assigned a value of 1.
Table 1
Response of Lucilia cuprina larvae to HDAC inhibitors and insecticides.
Compound Weight gain in ﬁrst 24 h Pupation
IC50 (mg/assay) 95% CI IC50 (mg/assay) 95% CI
TSA 10.4 5.3e20.4 20.6 16.0e26.6
SAHA 434 247e763 1327 1026e1717
Cyromazine 1.27 0.62e2.59 1.36 0.05e34.48
Diﬂubenzuron 0.23 0.13e0.40 0.12 0.09e0.15
Dicyclanil 0.12 0.01e0.97 0.06 0.03e0.10
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and human HDACs, alongside the transcription proﬁling data,
highlights blowﬂy HDAC6 as potentially the most important
insecticide target among the set of blowﬂy HDACs. The two cata-
lytic domains of blowﬂy HDAC6 showed the least homology to their
human homologues. HDAC6 was transcribed at higher levels than
HDACs 3, 4 and 11, while being equivalent to HDAC1, at the day 1
time point of our sampling schedule, representing the early larval
stages (1st instar) when it is most desirable to inhibit the devel-
opment of the larvae before they damage the host.
Many HDAC inhibitors are unstable due to the hydroxamate
component of their structures. While both TSA and SAHA are
known to have short half lives in mammalian plasma at 37 C (half
life < 2 h) (Konsoula and Jung, 2008), both are typically used in vitro
and in early in vivo studies to verify the importance of HDACFig. 5. Effects of insecticides (dashed lines) and HDAC inhibitors (solid lines) on
growth of blowﬂy larvae; A: effect on weight gain by larvae during the ﬁrst 24 h of
exposure to the compound; B: effect on pupation rate. Each data point represents
mean ± SE, n ¼ 3 separate experiments, each with a single assay at each compound
concentration.enzymes in biological systems. The stability of any proposed
insecticidal HDAC inhibitor will be very important for any blowﬂy
control chemical, and alternatives to hydroxamates as zinc-binding
ligands in HDAC inhibitors are still under investigation. However,
there are two aspects of inhibitor stability that are relevant: ﬁrstly,
stability over long periods in the sheep ﬂeece and on the skin
surface (several months), and secondly, stability in protein exu-
dates that form on the skin surfacewhen larvae initiate a strike. The
compounds will need to retain insecticidal activity in this protein
exudate environment for a period of at least several days to ensure
that the larvae derived from eggs laid by waves of gravid females
over this period cannot develop beyond the early larval stage.
HDAC inhibitors have been studied with respect to their po-
tential use as topical treatments, with a view to developing ameans
for rapid penetration into the skin for the treatment of melanoma
and arthritis (for example, Chung et al., 2004; Gowda et al., 2012).
On the other hand, as mentioned above, the use of HDAC inhibitors
as blowﬂy control agentswould rely onmaintenance of drugwithin
the skin surface/wool follicle environment for a period of several
months, and hence would most-likely rely on the type of formu-
lation chemistries currently used to bind blowﬂy control products
to the lanolin on wool ﬁbres (for example, Fleecebind™). A further
consideration impacting on the potential use of HDAC inhibitors as
insecticides for blowﬂy control will be the cost of such compounds.
The costs able to be borne by livestock enterprises for parasite
control are signiﬁcantly less than those considered acceptable for
drugs to be used in human health, particularly with respect to
cancer therapeutics. Likely production costs will be an important
component of future insecticide structure/activity studies and thus
HDAC inhibitors with longer half-lives and greater stabilities should
also not be too synthetically complex or expensive to produce.
In conclusion, the present study has identiﬁed important simi-
larities and differences between HDAC sequences and their tem-
poral expression in the sheep blowﬂy, L. cuprina. This information is
valuable in assessing both the viability of each HDAC as a new
insecticidal target, and the potential vulnerability of this species of
ﬂy to inhibition of different HDACs at different stages of its life
cycle. The study has also provided early proof of concept that HDAC
inhibitors might be viable as a new class of insecticides, with the
activity of the pan-HDAC inhibitor TSA being within 8-fold of the
in vitro potency of a commercial insecticide currently used to
control sheep blowﬂy. Further work will require development of
insect-speciﬁc HDAC inhibitors with sufﬁcient potency and stability
for use against insect pests in the ﬁeld. High-throughput parallel
assays using recombinant insect HDACs and mammalian enzymes
may provide a means of identifying potent insect-speciﬁc com-
pounds rather than relying on whole organism bioassays as
demonstrated here. The sequences of blowﬂy and other insect
HDACs studied here might also be aligned with crystal structures of
human HDACs to construct three dimensional structural models of
blowﬂy and other insect HDACs. Such structural models might
provide valuable insights into structural requirements needed for
developing HDAC-directed drugs with insect selectivity.Acknowledgement
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